Inventor
Peter Michael Wovkulich
Inventor
Nutley, NJ, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07CAcyclic or carbocyclic compounds10%
A61KPreparations for medical, dental or toiletry purposes7%
C07HSugars7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07JSteroids1%
PatentTitleYear
9,580,411'Substituted sulfonamide compounds'20179,353,096'Substituted phenylcarbamate compounds'20169,334,278'Pyrrolo[2,3-B]pyrazines as SYK inhibitors'20168,940,741'Inhibitors of bruton\'s tyrosine kinase'20158,658,646'Pyrrolopyrazine kinase inhibitors'20148,481,540'Inhibitors of bruton\'s tyrosine kinase'20138,044,213'Thiazolyl-benzimidazoles'20118,003,785'Halo-substituted pyrimidodiazepines'20117,851,626'4,4,5,5, tetrasubstituted imidazolines'20107,615,634'4-aminopyrimidine-5-one derivatives'20097,524,840'7,8-disubstituted pyrazolobenzodiazepines'20097,423,051'2,6-diaminopyridine derivatives'20087,157,455'4-Aminopyrimidine-5-one derivatives'20076,916,923'Method for synthesizing pyrazolobenzodiazepines'20056,838,558'Pyrazolobenzodiazepines'20056,440,959'Pyrazolobenzodiazepines'20025,200,549'Antipsoriatic agents'19935,120,722'Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia'19925,110,958'Compounds, process and intermediates'19925,073,568'Antipsoriatic agents'19914,632,784'Process for the preparation of 1.alpha.,23,25-trihydroxycholecalciferol-26-oic acid 23,26-lactone'19864,612,308'25,26-Dehydro-1.alpha.,23(S,R)-dihydroxycholecalciferol and its epimers'19864,594,432'Process for the synthesis of 1.alpha.,23(S),25-trihydroxycholecalciferol and 1.alpha.,23(R),25-trihydroxycholecalciferol'19864,415,742'Tetrahydro-5-(1-hydroxyethyl)-2-hydroxy-N(1-arylhydrocarbyl )furan-4-carbamic acid alkyl esters'19834,414,402'[2S-(2.beta.,2S*, 3.beta.)]-3-Aminotetrahydro-5-methoxy-.alpha.-methyl-2-furanmethanol, an intermediate in the chiral synthesis of amino sugars'19834,376,207'Chiral synthesis of amino sugars'19834,360,470'Process and intermediates for the synthesis of Vitamin D.sub.3 metabolites and chenodeoxycholic acid'19824,324,726'Chiral synthesis of amino sugars'19824,252,964'Furo[3,2-C]isoxazol-5-ones'1981Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1981–2017Patents assigned to HOFFMANN LA ROCHE (28)· patent assignee history
1981–2015Based in Nutley, NJ, US· patent location history
2013–2014Patents assigned to WOVKULICH PETER MICHAEL (2)· patent assignee history
2013Patents assigned to BERTHEL STEVEN JOSEPH (1)· patent assignee history
2013Patents assigned to BILLEDEAU ROLAND JOSEPH (1)· patent assignee history
2013Patents assigned to BROTHERTON-PLEISS CHRISTINE E (1)· patent assignee history
2016Based in Apalachin, NY, US· patent location history
2017Based in New York, NY, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOFFMANN LA ROCHE | 28 | 1981–2017 |
| WOVKULICH PETER MICHAELself | 2 | 2013–2014 |
| BERTHEL STEVEN JOSEPH | 1 | 2013 |
| BILLEDEAU ROLAND JOSEPH | 1 | 2013 |
| BROTHERTON-PLEISS CHRISTINE E | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Nutley, New Jersey, US | 26 | 1981–2015 |
| Apalachin, New York, US | 2 | 2016 |
| New York, New York, US | 1 | 2017 |